Replimune Group, Inc.
REPL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001737953
In the last 90 days, Replimune Group, Inc. insiders filed 0 open-market purchases and 5 sales; 199 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Replimune Group, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 101
- −9 vs. Q2 2021
- Shares held
- 35.4M
- +487.4K (+1.4%) vs. Q2 2021
- Total value
- $1.05B
- −$290.8M (−21.7%) vs. Q2 2021
- New holders
- 5
- 38 more added
- Sold out
- 14
- 34 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting REPL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 199 | $1.06B |
| Q1 2026 | 180 | $619.2M |
| Q4 2025 | 165 | $775.2M |
| Q3 2025 | 163 | $347.5M |
| Q2 2025 | 175 | $752.1M |
| Q1 2025 | 167 | $799.3M |
| Q4 2024 | 157 | $943.2M |
| Q3 2024 | 144 | $766.7M |
| Q2 2024 | 149 | $638.1M |
| Q1 2024 | 150 | $547.8M |
| Q4 2023 | 140 | $556.8M |
| Q3 2023 | 127 | $970.9M |
| Q2 2023 | 141 | $1.27B |
| Q1 2023 | 140 | $949.0M |
| Q4 2022 | 135 | $1.31B |
| Q3 2022 | 106 | $703.9M |
| Q2 2022 | 102 | $700.2M |
| Q1 2022 | 107 | $665.0M |
| Q4 2021 | 99 | $1.05B |
| Q3 2021 | 101 | $1.05B |
| Q2 2021 | 110 | $1.34B |
| Q1 2021 | 108 | $1.06B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Replimune Group, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Price T Rowe Associates Inc | 5,717,040 | $169.5M | 0.02% | +647,590+12.8% | Added |
| Corriente Advisors, LLC | 0 | $0 | 0.00% | −449,879−100.0% | Sold out |
| Tekla Capital Management LLC | 0 | $0 | 0.00% | −219,060−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −161,300−100.0% | Sold out |
| Sofinnova Investments, Inc. | 0 | $0 | 0.00% | −71,661−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −38,421−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −15,279−100.0% | Sold out |
| AlphaCrest Capital Management LLC | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −7,868−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −5,687−100.0% | Sold out |
| Quantitative Systematic Strategies LLC | 0 | $0 | 0.00% | −5,517−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −5,408−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −1,400−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −1,400−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −1,034−100.0% | Sold out |